These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 36504155)

  • 1. Meta-analysis of trans-hepatic artery chemoembolization combined with radiofrequency ablation versus transhepatic artery chemoembolization alone for recurrent liver cancer after hepatectomy.
    Ji B; Hao F; Wu X; Lu Z
    Asian J Surg; 2023 Apr; 46(4):1819-1821. PubMed ID: 36504155
    [No Abstract]   [Full Text] [Related]  

  • 2. Letter: repeat hepatic resection versus radiofrequency ablation for recurrent hepatocellular carcinoma in ideal candidates.
    Teng YX; Zhang WG; Chan AW; Chong CCN; Serenari M; Wang YY; Peng N; Huang T; Lu SD; Liang ZY; Ma L; Zhong JH
    Aliment Pharmacol Ther; 2023 Apr; 57(7):810-812. PubMed ID: 36913504
    [No Abstract]   [Full Text] [Related]  

  • 3. Letter: repeat hepatic resection versus radiofrequency ablation for recurrent hepatocellular carcinoma in ideal candidates - authors' reply.
    Tong Y; Chang DH; Xiao YD
    Aliment Pharmacol Ther; 2023 Apr; 57(7):813-814. PubMed ID: 36913502
    [No Abstract]   [Full Text] [Related]  

  • 4. Surgical resection versus radiofrequency ablation for the curative treatment of intrahepatic recurrent hepatocellular carcinoma: an unsolved question.
    Zizzo M; Sanguedolce F; Palicelli A; Ascani S; Zanelli M
    HPB (Oxford); 2022 Jun; 24(6):994-995. PubMed ID: 34980575
    [No Abstract]   [Full Text] [Related]  

  • 5. Combined transcatheter arterial chemoembolization and radiofrequency ablation versus hepatectomy for recurrent hepatocellular carcinoma after initial surgery: a propensity score matching study.
    Peng Z; Wei M; Chen S; Lin M; Jiang C; Mei J; Li B; Wang Y; Li J; Xie X; Kuang M
    Eur Radiol; 2018 Aug; 28(8):3522-3531. PubMed ID: 29536241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The 10-year Survival Analysis of Radiofrequency Ablation for Solitary Hepatocellular Carcinoma 5 cm or Smaller: Primary versus Recurrent HCC.
    Bai XM; Cui M; Yang W; Wang H; Wang S; Zhang ZY; Wu W; Chen MH; Yan K; Goldberg SN
    Radiology; 2021 Aug; 300(2):458-469. PubMed ID: 34003058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival outcome of salvage hepatectomy in patients with local, recurrent hepatocellular carcinoma who underwent radiofrequency ablation as their first treatment.
    Ueno M; Nakai T; Hayashi M; Hirokawa F; Nagano H; Wada H; Kaibori M; Matsui K; Tanaka S; Yamaue H; Kubo S
    Surgery; 2016 Sep; 160(3):661-70. PubMed ID: 27267547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Study of the risk factors for recurrence of early and late stage hepatocellular carcinoma after hepatic artery embolization combined with radiofrequency ablation therapy].
    Sun Y; Zhang HH; Zheng JS; Zhang YH
    Zhonghua Gan Zang Bing Za Zhi; 2021 Oct; 29(10):1001-1005. PubMed ID: 34814396
    [No Abstract]   [Full Text] [Related]  

  • 9. Transcatheter chemoembolization plus percutaneous radiofrequency ablation versus laparoscopic radiofrequency ablation: improved outcome for inoperable hepatocellular carcinoma.
    Chai B; Wang W; Wang F; Zhou G; Zheng C
    Int J Hyperthermia; 2021; 38(1):1685-1694. PubMed ID: 34843653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Percutaneous radiofrequency ablation combined with other minimally invasive treatments for recurrent hepatocellular carcinoma after hepatectomy].
    Xu L; Li P; Chen MS; Pang XH; Gao HJ; Peng ZW; Liang HH; Zhang YJ; Li JQ
    Zhonghua Wai Ke Za Zhi; 2008 Nov; 46(21):1617-20. PubMed ID: 19094753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Massive abdominal hemorrhage after radiofrequency ablation of recurrent hepatocellular carcinoma with successful hemostasis achieved through transarterial embolization: a case report.
    Shi QM; Xue C; He YT; Hu XB; Yu ZJ
    J Int Med Res; 2020 Feb; 48(2):300060519898012. PubMed ID: 32046546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the efficacy and safety of repeated hepatectomy and radiofrequency ablation in the treatment of primary recurrent liver cancer: a meta-analysis.
    Chen Z; Wang J; Lin Y
    World J Surg Oncol; 2022 Jun; 20(1):182. PubMed ID: 35668464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-intensity focused ultrasound alone or combined with transcatheter arterial chemoembolization for the treatment of hepatocellular carcinoma with unsuitable indications for hepatectomy and radiofrequency ablation: a phase II clinical trial.
    Gu L; Shen Z; Ji L; Ng DM; Du N; He N; Fan X; Yan K; Zheng Z; Chen B; Ma L; Qiu G; Chen P; Zheng J; Yang T
    Surg Endosc; 2022 Mar; 36(3):1857-1867. PubMed ID: 33788029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advanced Recurrent Hepatocellular Carcinoma: Treatment with Sorafenib Alone or in Combination with Transarterial Chemoembolization and Radiofrequency Ablation.
    Peng Z; Chen S; Wei M; Lin M; Jiang C; Mei J; Li B; Wang Y; Li J; Xie X; Chen M; Qian G; Kuang M
    Radiology; 2018 May; 287(2):705-714. PubMed ID: 29390197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic resection combined with radiofrequency ablation versus hepatic resection alone for multifocal hepatocellular carcinomas: A meta-analysis.
    Xu LL; Zhang M; Yi PS; Zheng XB; Feng L; Lan C; Tang JW; Ren SS; Xu MQ
    J Huazhong Univ Sci Technolog Med Sci; 2017 Dec; 37(6):974-980. PubMed ID: 29270762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiofrequency ablation combined with chemoembolization: treatment of recurrent hepatocellular carcinomas after hepatectomy.
    Takaki H; Yamakado K; Sakurai H; Nakatsuka A; Shiraki K; Isaji S; Takeda K
    AJR Am J Roentgenol; 2011 Aug; 197(2):488-94. PubMed ID: 21785099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repeat hepatic resection VS radiofrequency ablation for the treatment of recurrent hepatocellular carcinoma: an updated meta-analysis.
    Liu J; Zhao J; Gu HAO; Zhu Z
    Minim Invasive Ther Allied Technol; 2022 Mar; 31(3):332-341. PubMed ID: 33143517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcatheter arterial chemoembolization alone or combined with ablation for recurrent intermediate-stage hepatocellular carcinoma: a propensity score matching study.
    Wang C; Liao Y; Qiu J; Yuan Y; Zhang Y; Li K; Zou R; Wang Y; Zuo D; He W; Zheng Y; Li B; Yuan Y
    J Cancer Res Clin Oncol; 2020 Oct; 146(10):2669-2680. PubMed ID: 32449005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of neoadjuvant conventional transarterial chemoembolization with radiofrequency ablation in the treatment of recurrent hepatocellular carcinoma after initial hepatectomy with microvascular invasion.
    Peng Z; Wu X; Li J; Pang H; Zhang Y; Lin M; Wang Z; Xiao H; Li B; Chen M; Feng S; Kuang M; Chen S
    Int J Hyperthermia; 2022; 39(1):688-696. PubMed ID: 35469522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiofrequency ablation versus repeat resection for recurrent hepatocellular carcinoma (≤ 5 cm) after initial curative resection.
    Feng Y; Wu H; Huang DQ; Xu C; Zheng H; Maeda M; Zhao X; Wang L; Xiao F; Lv H; Liu T; Qi J; Li J; Zhong N; Wang C; Feng H; Liang B; Ren W; Qin C; Nguyen MH; Zhu Q
    Eur Radiol; 2020 Nov; 30(11):6357-6368. PubMed ID: 32529568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.